Total raised
$1.0M
Last: Seed 2025-01
Stage
Seed
Founded
2021
Headcount
11
HQ
Ness Ziona
Sector
Health Tech & Life Sciences
About
Nanocarry is developing therapeutics based on bioengineered nanoparticles with novel capabilities to treat oncology indications and brain diseases. The company’s AxS platform can be easily modified to deliver a wide array of biologics, safely and effectively, to the brain and beyond.
Nanocarry’s first products in development are for brain metastases of HER2+ breast cancer and non-small cell lung cancer.
Funding history · 3 rounds · $1.0M total
2025-01
Seed
Undisclosed
2024-08
Undisclosed
Undisclosed
2021-10
Pre-Seed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital TherapeuticsPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticals
Business model
B2C
Tags
personalized-treatmentmedical-technologiescancertreatments